Table 3.
Reference | Was similarity between the two (or more) groups at baseline? | Was the trial described as randomized? | Was the randomization procedure described and appropriate? | Was the treatment allocation concealed? | Was the trial described as double‐blind? | Was the method of double blinding described and appropriate? | Was the number of withdrawals/dropouts in each group mentioned? | Was an analysis conducted on the intention to treat sample? | Jadad score |
---|---|---|---|---|---|---|---|---|---|
Akhondzadeh et al. 27 | Yes | Yes | No | No | Yes | No | Yes | Yes | 5 |
Tildesley et al. 4 | Yes | Yes | No | No | Yes | No | Yes | No | 3 |
Perry et al. 8 | Yes | No | No | No | No | No | Yes | Yes | 3 |
Tildesley et al. 18 | Yes | Yes | No | No | Yes | No | No | No | 3 |
Kennedy et al. 24 | Yes | Yes | Yes | No | Yes | No | No | N/A | 3 |
Scholey et al. 9 | Yes | Yes | Yes | No | Yes | No | No | No | 4 |
Moss et al. 26 | Yes | Yes | No | No | No | No | No | No | 2 |
Kennedy et al. 25 | Yes | Yes | No | Yes | Yes | Yes | No | No | 5 |